# Tracking Biologics Along the Silk Road

> **NCT03006198** · — · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 140 (actual)

## Conditions studied

- Arthritis, Rheumatoid; Spondylitis, Ankylosing; Arthritis, Psoriatic; Colitis, Ulcerative

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03006198
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-04
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2019-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03006198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03006198, "Tracking Biologics Along the Silk Road". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03006198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*